Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Baird Medical Investment Holdings (BDMD) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Baird Medical Investment Holdings (BDMD) over the last 3 years, with Q2 2025 value amounting to $2.2 million.

  • Baird Medical Investment Holdings' Cash & Equivalents rose 4376.13% to $2.2 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.2 million, marking a year-over-year increase of 4376.13%. This contributed to the annual value of $3.0 million for FY2024, which is 9663.89% up from last year.
  • According to the latest figures from Q2 2025, Baird Medical Investment Holdings' Cash & Equivalents is $2.2 million, which was up 4376.13% from $3.0 million recorded in Q4 2024.
  • In the past 5 years, Baird Medical Investment Holdings' Cash & Equivalents ranged from a high of $3.0 million in Q4 2024 and a low of $1.5 million during Q4 2023
  • In the last 3 years, Baird Medical Investment Holdings' Cash & Equivalents had a median value of $1.8 million in 2023 and averaged $2.0 million.
  • Per our database at Business Quant, Baird Medical Investment Holdings' Cash & Equivalents skyrocketed by 9663.89% in 2024 and then soared by 4376.13% in 2025.
  • Quarter analysis of 3 years shows Baird Medical Investment Holdings' Cash & Equivalents stood at $1.5 million in 2023, then surged by 96.64% to $3.0 million in 2024, then fell by 26.89% to $2.2 million in 2025.
  • Its Cash & Equivalents was $2.2 million in Q2 2025, compared to $3.0 million in Q4 2024 and $1.5 million in Q2 2024.